Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
18 |
|
2003 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
17 |
|
2003 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
16 |
|
2003 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.070 |
None |
1.000 |
7 |
|
2009 |
2019 |
Bacterial Infections
|
group |
Infections
|
Disease or Syndrome
|
616
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Delirium, Dementia, Amnestic, Cognitive Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
83
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Parkinsonian Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
373
|
95
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Muscular Dystrophies, Limb-Girdle
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
118
|
37
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neurocognitive Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
79
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
11 |
|
2003 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2019 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Addictive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
332
|
56
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |